In NB, attempts have been made to target MYCN‐MAX dimerization or inhibit MYCN‐MAX binding to DNA to block and arrest tumour development, and this has been a very long‐standing and relatively attractive perspective. This evidence concerns the gene MYCN and neuroblastoma.